Author:
Mayer Erica L.,Isakoff Steven J.,Klement Giannoula,Downing Sean R.,Chen Wendy Y.,Hannagan Keri,Gelman Rebecca,Winer Eric P.,Burstein Harold J.
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Gasparini G (1999) Angiogenesis in breast cancer: role in biology, tumor progression, and prognosis. In: Bowcock A (ed) Breast cancer: molecular genetics, pathogenesis and therapeutics. Humana Press, Totowa, pp 347–371
2. Sledge GW Jr (2002) Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects. Semin Oncol 29:104–110
3. Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358:2039–2049
4. O’Shaughnessy J, Miles D, Gray R, Dieras V, Perez E, Zon R, Cortes J, Zhou X, Phan S, Miller K (2010) A meta-analysis of overall survival data from three randomized trials of bevacizumab (BV) and first-line chemotherapy as treatment for patients with metastatic breast cancer (MBC). J Clin Oncol 28:A1005
5. Sandler A, Gray R, Perry MC, Brahmer J, Schiller J, Dowlati A, Lilienbaum R, Johnson D (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N Engl J Med 355:2542–2550
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献